Skip to NavigationSkip to content

News

The FDA is looking into if the diabetes drug metformin has unsafe levels of a cancer-causing chemical.
Sage Therapeutics has announced that its candidate SAGE-217 flopped in Phase 3 trials investigating its efficacy in symptom reduction for major...
Over 140,000 people died from measles last year, with most of them being children under five, according to World Health Organization (WHO) and the US...
Widespread bribery in India’s pharma industry, Purdue Pharma President ignored addiction concerns with OxyContin, and Lynparza scores NICE...
The FDA has approved the first three generic versions of Novartis’ sphingosine 1-phosphate receptor modulator Gilenya (fingolimod) to treat adult...
NDA's Lisa Peluso, Director, Coaching and Client Engagement, outlines key strategies for interacting with audiences and payers while maximising...
Novartis is teaming up with Amazon Web Services to utilise its cloud computing technology. The collaboration is designed to overhaul Novartis’s...
A person has been diagnosed with the rare viral infection monkeypox in South West England. It is believed they contracted it while staying in...
The number of illegal diazepam tablets seized by the UK Border Force has doubled in a year, going from 545,000 in 2017 to 1.3 million in 2018.
A team of biomedical scientists at the University of California has found that a FDA-approved drug for treating rheumatoid arthritis and ulcerative...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches